期刊文献+

免煎中药治疗尿毒症性营养不良-炎症综合征的探讨 被引量:5

Study on the Treatment of Uremic Malnutrition Inflammation Syndrome with Non-decocted Chinese Medicine
下载PDF
导出
摘要 目的探讨参苓白术散联合红芪配方治疗尿毒症性营养不良-炎症综合征的疗效及机制。方法 100例尿毒症性营养不良-炎症综合征患者随机分为常规治疗组以及参苓白术散联合红芪治疗组,按照分组给予相应治疗,比较治疗后两组间营养状态指标、炎症指标以及瘦素水平。结果所有患者均顺利完成治疗,治疗后组间营养状态指标,参苓白术散联合红芪治疗组显著高于常规治疗组(P<0.01),炎症指标参苓白术散联合红芪治疗组显著低于常规治疗组(P<0.01),两组间治疗后瘦素水平无显著差异。结论参苓白术散联合红芪治疗通过改善尿毒症患者的微炎症状态、促进患者机体对营养物质的吸收起到治疗尿毒症性营养不良-炎症综合征的作用。 Objective To investigate the effect and mechanism of Shenling Baizhu powder cooperated with Hedysari in the treatment of uremic malnutrition inflammation syndrome. Methods 100 cases of patients with uremic malnutrition inflammation syndrome were divided into Shenling Baizhu powder cooperated with Hedysari group and conventional hemodialysis group. The patients were given the appropriate treatment in accordance with grouping. At the end of the treatment,nutritional status indicators,inflammatory markers,and leptin levels were compared. Results All patients went through the treatment successfully. Nutritional status indicators of Shenling Baizhu powder cooperated with Hedysari group were significantly higher than that of the conventional hemodialysis group,while the inflammatory markers were just on the contrary. There were no significant differences between the leptin levels. Conclusion Shenling Baizhu powder cooperated with Hedysari can act as an effective treatment of uremic malnutrition-inflammation syndrome through the mechanism of improving microinflammation and promoting nutrients absorption.
出处 《光明中医》 2016年第17期2447-2451,共5页 GUANGMING JOURNAL OF CHINESE MEDICINE
基金 福州市科技计划项目(No.2012-S-154-6)
关键词 参苓白术散 红芪 尿毒症性营养不良-炎症综合征 Shenling Baizhu powder Hedysari Uremic malnutrition inflammation syndrome
  • 相关文献

参考文献10

  • 1Pupim LB, Flakol 1 PJ, Ikizler TA. Protein homeostasis in chronic hemodialysis patients[ J]. Curr Opin Clin Nutr Metab Care, 2004,7 ( 1 ) :89-95.
  • 2Szet o CC, Chow KM, Leung CB, et al. Assessment of protein nit rogen appearance in Chinese peritoneal dialysis patients-which method to use[J]. Ren Fail, 2003,25(2) :235-246.
  • 3Kalantar-ZadehK, Block G, HumphreysMH. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients [ J 1. Kidney Int, 2003,63 ( 3 ) : 793 -808.
  • 4Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end- stage renal disease patients[J]. Am J Kidney Dis, 2002,40(2) :307-314.
  • 5specific factors on nutritional status and survival in hemodialysis[ J]. J Ren Nutr, 2004, 14(2) :72-81.
  • 6Lorenzo V, Martin M, Ruf ino M, et al. High prevalence of overweight in a stable Spanish hemodialysis population: a cross sectional study[ J]. J Ren Nutr, 2003, 13 ( 1 ) :52-59.
  • 7杨林,谭玉玲.中药红芪研究现状[J].中外医疗,2010,29(5):120-121. 被引量:32
  • 8杨小虎,郭延生,曲亚玲,华永丽,杜天玺,杨洪申,魏彦明.红芪、黄芪水提液体外清除自由基作用的研究[J].甘肃农业大学学报,2010,45(4):42-45. 被引量:29
  • 9袁伟杰.慢性肾衰竭营养治疗的原理及实践[J].中国中西医结合肾病杂志,2004,5(1):1-4. 被引量:10
  • 10王天生.尿毒症患者微炎症状态与营养不良的研究进展[J].海南医学,2006,17(3):120-121. 被引量:4

二级参考文献45

共引文献66

同被引文献54

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部